Cargando…
Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported a cell sur...
Autores principales: | Meng, Panpan, Zhang, Yi-Fan, Zhang, Wangli, Chen, Xin, Xu, Tong, Hu, Sheng, Liang, Xinjun, Feng, Mingqian, Yang, Xiaoqing, Ho, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794441/ https://www.ncbi.nlm.nih.gov/pubmed/33420124 http://dx.doi.org/10.1038/s41598-020-79524-3 |
Ejemplares similares
-
Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
por: Wang, Chunguang, et al.
Publicado: (2016) -
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signaling and protein synthesis
por: Gao, Wei, et al.
Publicado: (2015) -
Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
por: Fleming, Bryan D., et al.
Publicado: (2016) -
The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer
por: Kolluri, Aarti, et al.
Publicado: (2019) -
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
por: Fleming, Bryan D., et al.
Publicado: (2020)